Vinzent Rolny
Overview
Explore the profile of Vinzent Rolny including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kohansal-Nodehi M, Lange M, Kroeniger K, Rolny V, Tabares G, Piratvisuth T, et al.
Front Oncol
. 2023 Nov;
13:1213898.
PMID: 37920152
Background: There is a need for new serum biomarkers for early detection of hepatocellular carcinoma (HCC). Haptoglobin (Hp) N-glycosylation is altered in HCC, but the diagnostic value of site-specific Hp...
2.
Muley T, Schneider M, Meister M, Thomas M, Heussel C, Kriegsmann M, et al.
Tumour Biol
. 2023 Oct;
46(s1):S163-S175.
PMID: 37840516
Background: Serum tumor markers (STM) may complement imaging and provide additional clinical information for patients with non-small cell lung cancer (NSCLC). Objective: To determine whether STMs can predict outcomes in...
3.
Mang A, Zou W, Rolny V, Reck M, Cigoianu D, Schulze K, et al.
Tumour Biol
. 2023 Aug;
46(s1):S177-S190.
PMID: 37545290
Background: Patients with non-small cell lung cancer (NSCLC) and stable disease (SD) have an unmet clinical need to help guide early treatment adjustments. Objective: To evaluate the potential of tumor...
4.
Malik J, Klammer M, Rolny V, Chan H, Piratvisuth T, Tanwandee T, et al.
World J Gastroenterol
. 2022 Sep;
28(29):3917-3933.
PMID: 36157551
Background: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Current guidelines for HCC management recommend surveillance of high-risk patients every 6 mo using ultrasonography. Serum biomarkers,...
5.
Moseby-Knappe M, Levin H, Blennow K, Ullen S, Zetterberg H, Lilja G, et al.
Resusc Plus
. 2022 Jun;
10:100258.
PMID: 35677835
Background: Several biochemical markers in blood correlate with the magnitude of brain injury and may be used to predict neurological outcome after cardiac arrest. We present a protocol for the...
6.
Chan H, Vogel A, Berg T, De Toni E, Kudo M, Trojan J, et al.
JGH Open
. 2022 May;
6(5):292-300.
PMID: 35601131
Background And Aims: Prothrombin induced by vitamin K absence-II (PIVKA-II) is a serum biomarker linked to hepatocellular carcinoma (HCC), showing superiority to alpha-fetoprotein (AFP) for early disease detection. We aimed...
7.
Krisai P, Eken C, Aeschbacher S, Coslovsky M, Rolny V, Carmine D, et al.
J Stroke
. 2021 Oct;
23(3):449-452.
PMID: 34649390
No abstract available.
8.
Elmenhorst E, Griefahn B, Rolny V, Basner M
Int J Environ Res Public Health
. 2019 Mar;
16(6).
PMID: 30917492
Objectives: Air, road, and railway traffic, the three major sources of traffic noise, have been reported to differently impact on annoyance. However, these findings may not be transferable to physiological...
9.
Lang R, Rolny V, Leinenbach A, Karl J, Lange M, Kobold U, et al.
Tumour Biol
. 2019 Mar;
41(3):1010428319827223.
PMID: 30907281
Prostate cancer represents a major cause of cancer death in men worldwide. Novel non-invasive methods are still required for differentiation of non-aggressive from aggressive tumors. Recently, changes in prostate-specific antigen...
10.
Muley T, He Y, Rolny V, Wehnl B, Escherich A, Warth A, et al.
Lung Cancer
. 2019 Mar;
130:194-200.
PMID: 30885344
Objectives: The biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymis protein 4 (HE4) are useful in the diagnosis, prognosis, and monitoring of non-small cell lung cancer (NSCLC), but their...